Anson Funds

InterRent REIT is a real estate investment trust focused on enhancing Unitholder value through the acquisition and ownership of multi-residential properties across Canada. The organization aims to expand its portfolio in markets with stable vacancies and sufficient available units to facilitate effective management. InterRent's primary goals include providing Unitholders with stable and growing cash distributions from a diversified property portfolio, enhancing asset value through active management, and increasing distributable income via strategic acquisitions. Revenue is generated from rental income as well as ancillary services such as parking and laundry. The company emphasizes a conservative payout ratio to maintain a healthy balance sheet while pursuing growth.

NRx Pharmaceuticals is a clinical-stage pharmaceutical company focused on developing innovative therapeutics for central nervous system disorders and life-threatening pulmonary diseases. The company aims to address critical health challenges by researching and scaling solutions for conditions that often remain untreated. Notably, NRx has announced the commercialization of ZYESAMI (Aviptadil), which targets COVID-related respiratory failure. Additionally, the company is advancing NRX-100/101, a pioneering sequential drug regimen designed for the treatment of bipolar depression in patients experiencing acute suicidal ideation and behavior. In a significant development, NRx was granted exclusive worldwide rights to develop and market the BriLife COVID vaccine by the Government of Israel, further expanding its portfolio in the fight against serious health threats.

Lions Gate Entertainment Corp. is a global content company engaged in the production and distribution of motion pictures, television programming, and digital content. Founded in 1986 and headquartered in Santa Monica, California, the company operates through three main segments: Motion Picture, Television Production, and Media Networks. The Motion Picture segment focuses on developing and producing feature films, including acquiring distribution rights and licensing films worldwide. The Television Production segment develops, produces, and distributes various television content, including series and non-fiction programming, while also managing the licensing of its original productions. This segment generates significant revenue by syndicating approximately 70 television shows across multiple networks. The Media Networks segment facilitates the distribution of STARZ branded premium subscription services both domestically and internationally, enhancing its presence in the streaming market. Lionsgate is recognized for its commitment to bold and innovative entertainment, appealing to diverse audiences globally.

NRx Pharmaceuticals is a clinical-stage pharmaceutical company focused on developing innovative therapeutics for central nervous system disorders and life-threatening pulmonary diseases. The company aims to address critical health challenges by researching and scaling solutions for conditions that often remain untreated. Notably, NRx has announced the commercialization of ZYESAMI (Aviptadil), which targets COVID-related respiratory failure. Additionally, the company is advancing NRX-100/101, a pioneering sequential drug regimen designed for the treatment of bipolar depression in patients experiencing acute suicidal ideation and behavior. In a significant development, NRx was granted exclusive worldwide rights to develop and market the BriLife COVID vaccine by the Government of Israel, further expanding its portfolio in the fight against serious health threats.

View, Inc., established in 2006 and headquartered in Milpitas, California, specializes in designing and manufacturing intelligent glass systems for various sectors, including workplace, healthcare, education, and hospitality. The company's flagship product, View Smart Windows, employs AI to automatically adjust in response to sunlight, enhancing natural light access and occupant experience, while minimizing heat and glare, and reducing energy consumption. Each View installation also includes a cloud-connected smart building platform, enabling further building optimization. With operations in the U.S. and internationally, View has improved over 90 million square feet of buildings, ranging from offices to multifamily residences.